Back to results
US 2022/0025469 A1Published application
Methods for computer processing sequence reads to detect molecular residual disease
AssigneeGuardant Health, Inc.
InventorsStefanie Ann Ward MORTIMER, AmirAli TALASAZ, Darya CHUDOVA, Helmy ELTOUKHY
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods for use in detection of molecular residual disease. The methods may comprise deep sequencing a panel of genomic regions in cell-free DNA molecules and computer processing sequence reads to detect variants that are indicative of molecular residual disease.
Claims22
A method for detecting molecular residual disease in a subject, the method comprising:
- (a) obtaining a plurality of cell-free deoxyribonucleic acid (cfDNA) molecules obtained or derived from the subject to generate amplified cfDNA molecules;
- (b) enriching a plurality of the cfDNA molecules for a sequencing panel of no more than twenty genomic regions to generate an enriched set of cfDNA molecules, wherein the sequencing panel of no more than twenty genomic regions is selected using information derived from a cancer tumor biopsy of the subject;
- (c) sequencing a plurality of the enriched set of amplified cfDNA molecules at a sequence read depth of at least about fifty thousand sequence reads per base to generate sequence reads;
- (d) computer processing a plurality of the sequence reads at least in part by aligning a plurality of the sequence reads to a reference genome to generate aligned sequence reads;
- (e) computer processing a plurality of the aligned sequence reads to detect a variant, thereby determining the molecular residual disease in the subject.
2 more elements
Dependencies are inferred from the claim text.